SPONSOR

University of Alabama at Birmingham

Total Trials

Recruiting

Phases

Phase 2, EARLY_Phase 1, Phase 1, Phase 3, Phase 1, Phase 2

Conditions studied: Chronic Myeloid Leukemia, Chronic Phase Adult CML Leukemia, Myeloid Leukemia,Myeloid, Chronic Spinal Cord Injuries Transverse Myelitis Fibromyalgia, Primary Obesity Prevention Weight Change Weight Loss

University of Alabama at Birmingham is a clinical research sponsor with 27 registered studies on ClinicalTrials.gov, of which 27 are actively recruiting participants. Research covers conditions including Chronic Myeloid Leukemia, Chronic Phase, Adult CML, Leukemia, Myeloid, Leukemia,Myeloid, Chronic.

The trial portfolio spans Phase 2, EARLY_Phase 1, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — University of Alabama at Birmingham

How many clinical trials has University of Alabama at Birmingham sponsored?

ClinicalMetric currently tracks 27 clinical trials sponsored by University of Alabama at Birmingham, of which 27 are actively recruiting participants. These trials cover conditions including Chronic Myeloid Leukemia, Chronic Phase, Adult CML, Leukemia, Myeloid. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does University of Alabama at Birmingham research focus on?

University of Alabama at Birmingham clinical trials span Chronic Myeloid Leukemia, Chronic Phase, Adult CML, Leukemia, Myeloid, Leukemia,Myeloid, Chronic, Spinal Cord Injuries, and additional conditions. The research pipeline includes Phase 2, EARLY_Phase 1, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a University of Alabama at Birmingham clinical trial?

To participate in a University of Alabama at Birmingham trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University of Alabama at Birmingham trials with current recruitment status updated daily.

University of Alabama at Birmingham

Frequently Asked Questions — University of Alabama at Birmingham

Clinical Trials by University of Alabama at Birmingham

Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase

The Impact of Expressive Emotional Writing on Facilitating Grief Resolution in Adults With Spinal Cord Injury

Psilocybin-facilitated Treatment for Chronic Pain

Optimizing an Extended Care Intervention to Promote Weight Loss Maintenance

Diet and Cognitive Training in Hematologic Cancer Survivors

PrOTECT AL: PrEP Optimization Through Enhanced Continuum Tracking

Sequence of Midurethral Sling Placement During Robotic Sacrocolpopexy

O. Formigenes Colonization in Calcium Oxalate Kidney Stone Disease

Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Disease

Minimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia (MILESTONE)

UAB 2419-CD34 Selection Using the Automated CliniMACS Prodigy

Glucose Metabolism in Cystic Fibrosis Related Diabetes (CFRD)

Improved Successful Retrieval Rate of HydroMARK Plus Breast Biopsy Site Marker in Comparison to HydroMARK as Well as Improved Surgeon Satisfaction

Trauma Resuscitation With Low-Titer Group O Whole Blood or Products

Using taVNS to Modulate Cardiovascular Function in Individuals With Neurologic Disease

Histiocytic Disorder Follow-up Study

Safety and Efficacy of Carbon Dioxide Gas for Endoscopy

Newly Diagnosed Stage III/IV Ovarian Cancer, Neoadjuvant Carbo/Taxol/Pembro, Maintenance Olaparib/Pembro

Ivacaftor for Acquired CFTR Dysfunction in Chronic Rhinosinusitis

Human iPSC for Repair of Vasodegenerative Vessels in Diabetic Retinopathy

The University of Alabama at Birmingham (UAB) Neuroinflammation in Parkinson's Disease-TSPO- Positron Emission Tomography (PET) Substudy

The Effect of Light Intervention on Recovery in Individuals With Opioid Use Disorder (OUD)

Ketogenic Diets for Weight Loss Maintenance: Impact on Energy Expenditure and Appetite in Individuals With Obesity

The ARISE Study - Use of Vertical Positioning

Establishment of an Interdisciplinary Functional Neurological Disorder (FND) Treatment Program and Development of a Clinical Care Pathway for FND

Housing, Environment, And Living Conditions for Transformed Health

UAB Alzheimer's Disease Center Core Cohort - Tau Imaging Substudy